Premium
Topical brimonidine tartrate 0·33% gel effectively reduces the post‐treatment erythema of daylight‐activated photodynamic therapy
Author(s) -
Gerber P.A.
Publication year - 2016
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.14384
Subject(s) - photodynamic therapy , brimonidine , daylight , medicine , dermatology , erythema , ophthalmology , chemistry , optics , physics , intraocular pressure , organic chemistry